Showing results (1211-1220 of 1,798) with videos related to

Sort By:
Pageof 180
Mabs|September 6, 2018
Preclinical pharmacokinetics and pharmacodynamics of DCLL9718A: An antibody-drug conjugate for the treatment of acute myeloid leukemiaDouglas D Leipold, Isabel Figueroa, Shabkhaiz Masih, et al.
Mabs|September 11, 2018
Non-neutralizing antibodies increase endogenous circulating Ang1 levelsChao Zheng, Joshuaine Toth, Tammy Bigwarfe, et al.
Mabs|September 14, 2018
Antigen binding allosterically promotes Fc receptor recognitionJun Zhao, Ruth Nussinov, Buyong Ma
Mabs|August 29, 2018
A systematic approach for analysis and characterization of mispairing in bispecific antibodies with asymmetric architectureChunlei Wang, Bhargavi Vemulapalli, Mingyan Cao, et al.
Mabs|August 30, 2018
Biosimilars in oncology and inflammatory diseases: current and future considerations for clinicians in Latin AmericaMorton Scheinberg, Carlos Pineda, Gilberto Castañeda-Hernández, et al.
Mabs|February 13, 2010
Antibody immunosuppressive therapy in solid-organ transplant: Part INadim Mahmud, Dusko Klipa, Nasimul Ahsan
Mabs|February 13, 2010
Engineered Fc variant antibodies with enhanced ability to recruit complement and mediate effector functionsGregory L Moore, Hsing Chen, Sher Karki, et al.
Mabs|September 9, 2016
Evading pre-existing anti-hinge antibody binding by hinge engineeringHok Seon Kim, Ingrid Kim, Linda Zheng, et al.
Mabs|February 20, 2010
Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technologyJody D Berry, Kevin Hay, James M Rini, et al.
Mabs|September 3, 2016
The underlying inflammatory chronic disease influences infliximab pharmacokineticsChristophe Passot, Denis Mulleman, Theodora Bejan-Angoulvant, et al.
Pageof 180